Brief: Seelos Announces Amendment Of SLS-002 Agreement To Repurchase Significant Portion Of Royalties For SLS-002

Seelos Therapeutics

18/02/2021 12:17

Feb 18 (Reuters) - Seelos Therapeutics Inc  SEEL.O :
    * SEELOS THERAPEUTICS ANNOUNCES AMENDMENT OF SLS-002
AGREEMENT TO
REPURCHASE A SIGNIFICANT PORTION OF ROYALTIES FOR SLS-002
(INTRANASAL RACEMIC KETAMINE PROGRAM)
    * SEELOS THERAPEUTICS - UNDER AMENDMENT, FOR ADDITIONAL CASH
PAYMENTS, CO AGREED TO REPURCHASE 9% OF FUTURE ROYALTIES
    * SEELOS THERAPEUTICS - UNDER AMENDMENT, AGREED TO REDUCE
ROYALTY
OBLIGATIONS TO A MID-SINGLE DIGIT PERCENTAGE ON ANY FUTURE NET
SALES OF SLS-002
    * SEELOS THERAPEUTICS INC - PLAN TO FURTHER EVALUATE
KETAMINE IN
FRONT-LINE MAJOR DEPRESSION AND OTHER RELATED INDICATIONS

Source text for Eikon:  ID:nPn1Z0Twla 
Further company coverage:  SEEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))